Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer.

There was a highly significant increase in survival ( p = 0.0061) ( Fig. 8 B ), with none of the control mice surviving past 18 days, whereas 50% of the 11C12 plus IR-treated mice were alive 30 days later, at the end point of the study.

also in 132,142 other papers